RHÖN-KLINIKUM AG (RHKJF)
RHÖN-KLINIKUM Statistics
Share Statistics
RHÖN-KLINIKUM has 66.94M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 66.94M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 19 and the forward PE ratio is null. RHÖN-KLINIKUM's PEG ratio is 1.22.
| PE Ratio | 19 |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| Forward PS | n/a |
| PB Ratio | 0.64 |
| P/FCF Ratio | 14.4 |
| PEG Ratio | 1.22 |
Enterprise Valuation
RHÖN-KLINIKUM has an Enterprise Value (EV) of 693.59M.
| EV / Sales | 0.43 |
| EV / EBITDA | 5.67 |
| EV / EBIT | 5.44 |
| EV / FCF | 12.13 |
Financial Position
The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.23 |
| Quick Ratio | 2.14 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 1.22 |
| Debt / FCF | 2.62 |
| Interest Coverage | 14.16 |
Financial Efficiency
Return on Equity is 3.35% and Return on Invested Capital is 2.61%.
| Return on Equity | 3.35% |
| Return on Assets | 2.34% |
| Return on Invested Capital | 2.61% |
| Revenue Per Employee | $113,429.94 |
| Profits Per Employee | $3,081.75 |
| Employee Count | 14,067 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 38.01 |
Taxes
| Income Tax | 11M |
| Effective Tax Rate | 19.57% |
Stock Price Statistics
The stock price has increased by 31.78% in the last 52 weeks. The beta is -0.03, so RHÖN-KLINIKUM's price volatility has been lower than the market average.
| Beta | -0.03 |
| 52-Week Price Change | 31.78% |
| 50-Day Moving Average | 15.3 |
| 200-Day Moving Average | 14.05 |
| Relative Strength Index (RSI) | 98.62 |
| Average Volume (20 Days) | 370 |
Income Statement
In the last 12 months, RHÖN-KLINIKUM had revenue of 1.6B and earned 43.35M in profits. Earnings per share was 0.67.
| Revenue | 1.6B |
| Gross Profit | 171.82M |
| Operating Income | 48.15M |
| Net Income | 43.35M |
| EBITDA | 122.23M |
| EBIT | 59.6M |
| Earnings Per Share (EPS) | 0.67 |
Balance Sheet
The company has 279.86M in cash and 149.6M in debt, giving a net cash position of 130.26M.
| Cash & Cash Equivalents | 279.86M |
| Total Debt | 149.6M |
| Net Cash | 130.26M |
| Retained Earnings | n/a |
| Total Assets | 1.86B |
| Working Capital | 499.26M |
Cash Flow
In the last 12 months, operating cash flow was 127.6M and capital expenditures -70.4M, giving a free cash flow of 57.2M.
| Operating Cash Flow | 127.6M |
| Capital Expenditures | -70.4M |
| Free Cash Flow | 57.2M |
| FCF Per Share | 0.89 |
Margins
Gross margin is 10.77%, with operating and profit margins of 3.02% and 2.72%.
| Gross Margin | 10.77% |
| Operating Margin | 3.02% |
| Pretax Margin | 3.52% |
| Profit Margin | 2.72% |
| EBITDA Margin | 7.66% |
| EBIT Margin | 3.02% |
| FCF Margin | 3.58% |
Dividends & Yields
RHKJF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 5.26% |
| FCF Yield | 6.94% |
Analyst Forecast
Currently there are no analyst rating for RHKJF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jul 24, 2009. It was a forward split with a ratio of 1033:1000.
| Last Split Date | Jul 24, 2009 |
| Split Type | forward |
| Split Ratio | 1033:1000 |
Scores
| Altman Z-Score | 2.51 |
| Piotroski F-Score | 7 |